Jervell and Lange-Nielsen Syndrome (JLNS)

Sponsored diagnostic testing programs for Jervell and Lange-Nielsen Syndrome (JLNS)

Jervell and Lange-Nielsen syndrome (JLNS) is a rare inherited arrhythmia disorder marked by congenital sensorineural hearing loss and significant prolongation of the QT interval. Affected individuals are at high risk for fainting, seizures, and life-threatening ventricular arrhythmias, often beginning in childhood. Genetic testing helps confirm the diagnosis and guide management.

1 program found for Jervell and Lange-Nielsen Syndrome (JLNS)

Programs

1 program
Invitae Unlock™

Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel

The Invitae Unlock™ Cardiomyopathy & Arrhythmia program offers sponsored genetic testing for U.S. patients with suspected inherited cardiomyopathy or arrhythmia. The comprehensive panel supports diagnostic clarification, risk assessment, and family variant identification. The test is billed to insurance first; when a claim is denied or the patient is uninsured, the program's sponsor covers the cost of testing. Testing must be ordered by a qualified healthcare provider.

Cardiology
ViewOrder
Performing lab
Invitae | Labcorp